There are currently 4 vaccines in China-2 of which come from SinoPharm, and 1 each from Kexing Biological and CanSino Bio. They are all in the third phase of clinical trials, but they are all used on a large scale.
According to the Associated Press, senior executives of Sinopharm Group disclosed that in addition to 40,000 clinical trial personnel, the subsidiary China Biotechnology Co., Ltd. (CNBG) has also provided vaccines to another 350,000; SinoVac (SinoVac) ) Nearly 3,000 employees and their families have been vaccinated; the vaccine jointly developed by the Chinese military and CanSinoBIO was approved for emergency use earlier.
The writer "Ten Years of Chopping Wood" recently exposed the hidden concerns of CCP's SARS-CoV-2 vaccines on Sina Medical News. He had been tested on a Chinese biotech vaccine. When he received the first shot on 22 July, he felt a little nauseous. He sat for half an hour before leaving. During the second shot on 24 August, he had a greater response and he drove back. He suddenly went dizzy while driving home, a bit like drunk driving, He had to stop the car to take a rest to feel better.
However, the Chinese Health Commission emphasized that none of the vaccines had "serious" side effects in clinical trials. The vaccines put into emergency use are safe, and the efficacy has not been determined. At present, the vaccines are mainly used by medical or customs personnel and business people abroad. The Health Commission declined to inform the exact number of people who have been vaccinated.
However, large Chinese companies such as Huawei and Phoenix Satellite TV have announced that they have cooperated with SinoPharm to purchase vaccines for their employees. Several people working in front-line companies even revealed that the company provided a vaccination subsidy of 1,000 RMB.
According to Diego Silva, a bioethics expert at the University of Sydney, Australia, according to official Chinese figures, there are currently very few cases of local transmission. Therefore, providing vaccines to a large number of people outside of clinical trials has no value in scientific research. A country like the United States where covid is raging is justified.
This is not only a moral and academic criticism of China's random use of vaccines, but also makes the outside world question whether the CCP's official epidemic notification is concealed?
Joy Zhang, a professor of scientific ethics at the University of Kent in the United Kingdom, criticized that Chinese companies are not transparent on issues such as informed consent, because SinoPharm’s website cannot find any core information about vaccines, except for showing off in international medical journals. Apart from the published papers, there is almost no other public information.
Fang Zhouzi questioned on Twitter, "The domestic SARS-CoV-2 vaccine Phase III clinical trial only started in August, and the results will not be available until the end of the year at the earliest. Now it has been highly publicized that it is safe and effective. When the result is not good, you can only hide it and say it is better. It is the most worrying. China's vaccine research and development capabilities are not strong, and there is no world-first precedent. The vaccines currently used are all imitations, and it is recognized that the quality is not as good as imported vaccines. It is a miracle to suddenly lead the world in the development of SARS-CoV-2 vaccines.
In addition to worrying about quality, the price of vaccines produced in China should not be underestimated. According to the BBC, the known pricing of single-dose vaccines worldwide ranges from RMB 20 to RMB 300. Among the current market prices, the single most expensive vaccine comes from SinoPharm.
No comments:
Post a Comment